the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Saudi Arabia plans US$40b push into AI, New York Times reports

NEW YORK: Saudi Arabia’s government plans to create a fund of about US$40 billion (RM189.3 billion) to invest in artificial intelligence (AI), the New York Times reported on Tuesday (March 19), citing three people briefed on the plans.

Representatives of Saudi Arabia’s Public Investment Fund (PIF) have discussed a potential partnership with US venture capital firm Andreessen Horowitz and other financiers in recent weeks, the newspaper reported.

Andreessen Horowitz and PIF governor Yasir Al-Rumayyan have discussed the possibility of the US firm setting up an office in Riyadh, according to the report.

PIF officials also discussed what role Andreessen Horowitz could play and how such a fund would work, the newspaper said, adding the plans could still change.

Other venture capitalists may participate in kingdom’s artificial intelligence fund, which is expected to commence in the second half of 2024, the newspaper said.

Saudi representatives have indicated to potential partners that the country is interested in supporting a variety of tech startups associated with artificial intelligence, including chip makers and large-scale data centers, the report added.

PIF and Andreessen Horowitz did not immediately respond to requests for comment from Reuters.

Last month, PIF’s Al-Rumayyan pitched the kingdom as a prospective hub for artificial intelligence activity outside US, citing its energy resources and funding capacity.

Al-Rumayyan had said the kingdom had the “political will” to make AI projects happen and ample funds it could deploy to nurture the technology’s development. – Reuters

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings